May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Regulation of Myocilin Expression Through the JNK Pathway in Porcine Trabecular Meshwork Cells
Author Affiliations & Notes
  • M. Hosseini
    Ophthalmology, Casey Eye Institute- Oregon Health & Science University, Portland, OR, United States
  • M.J. Kelley
    Ophthalmology, Casey Eye Institute- Oregon Health & Science University, Portland, OR, United States
  • T.S. Acott
    Ophthalmology, Casey Eye Institute- Oregon Health & Science University, Portland, OR, United States
  • Footnotes
    Commercial Relationships  M. Hosseini, None; M.J. Kelley, None; T.S. Acott, Alcon F.
  • Footnotes
    Support  NEI EY03279, EY08247, EY10572, RPB, GRF, Alcon Labs, Kettering Family Foundation
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1164. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      M. Hosseini, M.J. Kelley, T.S. Acott; The Regulation of Myocilin Expression Through the JNK Pathway in Porcine Trabecular Meshwork Cells . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1164.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the role of the JNK-MAP kinase pathway in the regulation of myocilin production in trabecular meshwork cells. Methods: Porcine trabecular meshwork cells were subjected to 10% mechanical stretch, TNFα (10 ng/ml) or IL-1α (10-25 ng/ml) treatment with or without JNK inhibitor II (20-30 µM) for 24, 48 and 72 hours. Western immunoblot analysis was used to examine the effect of JNK inhibitor II on S63 and S73 c-jun phosphorylation as well as a time course of myocilin expression. Results: Mechanical stretch, TNFα and IL-1α treatment all significantly increase the production and secretion of myocilin into the culture medium. Much of the secreted myocilin is the 65 kDa glycosylated form but the 55 kDa non-glycosylated form, the 75 kDa aggregate, and a 37 kDa proteolyzed form were also present with and without treatment. Inhibiting JNK completely blocks TNFα induction of myocilin, whereas it only partially blocks IL-1α induction. Western blot studies show a reduction in c-jun phosphorylation at S63 and S73 when cells are treated with JNK inhibitor II. Conclusions: The data suggest that more than one pathway controls the expression of myocilin and that TNFα induction of this protein requires JNK activity. Mechanical stretch and IL-1α, however, may use other pathways as well as the JNK-MAP kinase pathway. Further illumination of the various myocilin production pathways may provide insights into how this protein functions in normal and glaucomatous eyes.

Keywords: trabecular meshwork • signal transduction • proteins encoded by disease genes 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×